tiprankstipranks
Bristol-Myers Squibb (IT:1BMY)
:1BMY
Italy Market
1BMY
Bristol-Myers Squibb
RESEARCH TOOLSreports

Bristol-Myers Squibb (1BMY) Stock News & Sentiment

6 Followers
BMY Extends Admilparant Program, Reinforcing Its Bet on Pulmonary Fibrosis
Premium
Company Announcements
BMY Extends Admilparant Program, Reinforcing Its Bet on Pulmonary Fibrosis
5d ago
BMY
The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
14d ago
O
DE
Bristol-Myers Squibb’s Repotrectinib DDI Study: What Investors Should Watch
Premium
Company Announcements
Bristol-Myers Squibb’s Repotrectinib DDI Study: What Investors Should Watch
15d ago
BMY
Milvexian Phase 3 Wraps Up: What Bristol-Myers Squibb Investors Should Watch Next
Premium
Company Announcements
Milvexian Phase 3 Wraps Up: What Bristol-Myers Squibb Investors Should Watch Next
15d ago
BMY
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
Premium
Company Announcements
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
25d ago
BMY
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
Premium
Company Announcements
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
29d ago
BMY
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
Premium
Ratings
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
1M ago
BMY
More IT:1BMY News >

1BMY News on the Web

BMY Gains 10% Year to Date: Should You Buy, Sell or Hold the Stock?
Zacks
Bullish
Jim Cramer offers two trade ideas: One is a trim after a big run, the other is a buy
CNBC
Neutral
Bristol-Myers Squibb (BMY) Gets a Hold from RBC Capital
TipRanks News
Neutral
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
Zacks
Neutral
Bristol Myers price target lowered to $67 from $68 at BofA
TipRanks News
Neutral
Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts
Zacks
Neutral
We're exiting our position in a drug stock and initiating a stake in a more attractive rival
CNBC
Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday
CNBC
Neutral

News Score - Last 7 Days

Positive
IT:1BMY
Sector Average
Media Buzz
This Week17 articles
Weekly Average20.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IT:1BMY’s Media Buzz Sentiment?
17 articles about IT:1BMY were published this week. In an average week, 20.5 articles are published.
    What is IT:1BMY’s weekly average amount of articles?
    In an average week, 20.5 articles about IT:1BMY are published.
      What is IT:1BMY’s News Sentiment?
      100% of articles about IT:1BMY were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week